Moreover, upregulation of RIPK1 in tumor-associated macrophages (TAMs) contributes to immune tolerance and immunotherapeutic resistance in pancreatic ductal adenocarcinoma (Wang et al., 2020). This evidence concerns the gene RIPK1 and pancreatic ductal adenocarcinoma.